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Epidemiology of gastrointestinal symptoms
in young and middle-aged Swiss adults:
prevalences and comorbidities in a
longitudinal population cohort over
28 years
Maria Avramidou1* , Felix Angst1, Jules Angst2, André Aeschlimann1, Wulf Rössler2,3,4 and Ulrich Schnyder5
Abstract
Background: Although subacute and chronic gastrointestinal symptoms are very common in primary care,
epidemiological date are sparse. The aim of the study was to examine and quantify the prevalence of subacute and
chronic gastrointestinal symptoms and their associations with somatic and mental disorders in the general population.
Methods: Data were collected prospectively between 1981 (age m = 22, f = 23) and 2008 (age 49/50) from the Zurich
Cohort Study (n = 292 men, 299 women), a representative general population survey. The participants were assessed
using a semi-structured interview, the “Structured Psychopathological Interview and Rating of the Social Consequences
of Psychological Disturbances for Epidemiology” (SPIKE). Prevalence rates were computed to be representative of the
general population aged 22–50. Associations were quantified by odds ratios (ORs) and their 99% confidence
intervals (CI).
Results: The prevalences of intestinal and of gastric symptoms were significantly higher among women in all categories
examined. For example, any gastric symptoms: f. 26.4% vs m.15.2%; any intestinal symptoms: 27.6% vs 14.6%; nausea/
vomitus: 19.1% vs 4.5%; constipation: 15.8% vs 6.5% (all p < 0.001). Strong associations (all p < 0.0001) were
found between fatigue (1 month) and chronic stomach (OR = 9.96, 99%-CI: 5.53–17.94) and chronic intestinal
symptoms (OR = 9.02, 99%-CI: 4.92–16.54). Panic attacks were associated with subacute intestinal symptoms
(OR = 4.00, 99%-CI: 2.43–6.59). Anxiety was more strongly associated with subacute intestinal symptoms (OR = 3.37,
99%-CI: 2.23–5.08) than with subacute stomach symptoms (OR = 1.85, 1.20–2.86). Bipolar disorders were associated with
subacute stomach symptoms (OR = 1.83, 1.18–2.17) and unipolar depression with subacute intestinal
symptoms (OR = 2.05, 1.34–3.15).
Conclusions: Remarkably high prevalence rates of gastric and intestinal complaints were observed in women
(over 1/4; men 1/7). Fatigue/neurasthenia was the strongest co-factor in both conditions. Various syndromes
related to anxiety, phobia, and panic disorders showed further significant associations. The integration of
psychiatric and/or psychological treatment could help address the functional part of gastric and intestinal
syndromes.
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Background
Gastrointestinal (GI) symptoms are widespread and carry
heavy economic and social consequences. It is estimated
that in the United States 11% of the population suffer
from a chronic digestive disease, with a prevalence rate as
high as 35% for those 65 years and over [1]. In 2010 alone,
a reported 60 to 70 million people in the United States
suffered from a digestive disease [2]. Although subacute
and chronic gastrointestinal symptoms are very common,
there has so far been no thorough investigation of the
relevant Swiss epidemiological data, including the possible
associations of gastrointestinal symptoms with somatic
and psychiatric disorders in the general population.
Functional gastrointestinal disorders (FGIDs), repre-
sented by functional dyspepsia (FD) and irritable bowel
syndrome (IBS), include variable combinations of chronic
or acute gastrointestinal symptoms not explained by
structural or biochemical abnormalities [3–5]. Worldwide
the prevalence rates in the general population of dyspep-
sia/FD and IBS according to Rome III diagnostic criteria
are 5.3–20.4% and 1.1–29.2%, respectively. Recent reports
on Rome III FD and IBS indicate a female predominance
[6, 7]. The prevalence of IBS subtypes is characterised by a
male predominance for IBS with diarrhoea, and a female
predominance for IBS with constipation. Genetic and
environmental factors play an important role in the devel-
opment of FGIDs. Gene polymorphisms are involved in
the development of FGIDs. The prevalence of FGIDs dif-
fers across races and geographical areas. Food may also
affect their development, but the causal relationships are
not conclusive [8].
Psychosomatic concepts have long been postulated to
account for irritable bowel syndrome in the absence of
other objective aetiology and biomarkers, and it is com-
mon knowledge that many chronic conditions are associ-
ated with psychological disorders. It is worth noting that
ulcerative colitis was interpreted by psychosomatic theory
until the discovery of immune dysregulation [9].
In general, causal relationships are hard to establish.
Clinical and population-based studies worldwide have
found that some types of somatoform disorders (e.g.,
somatisation disorder, somatic-symptom-index (SSI) 4.6,
and pain disorder) frequently co-occur with anxiety and
depressive disorders. These findings could suggest either a
causal relationship between those disorders or that they
share certain aetiological factors. Irritable bowel syndrome
occurs most frequently in young adults in response to
emotional and other factors [10].
The aim of our analysis was to quantify the prevalence
of gastrointestinal symptoms in Swiss adults between
the ages of 22 (m)/23 (f ) and 49/50 years, i.e. over a
28-year period, stratified by duration into subacute
(1 week) and chronic (3 months, diarrhoea: 1 month).
In addition, their associations with a range of somatic
and psychiatric disorders were examined (see
Methods section below).
Based on the current literature [7], our first hypothesis
was that gastric and intestinal symptoms, especially
chronic symptoms, are more prevalent in women than
in men. Our second hypothesis was that there is a statis-
tically significant association between gastrointestinal
symptoms and certain psychiatric disorders, especially
anxiety, suggesting that some GI symptoms are partially
non-organic in nature.
Methods
Setting and data sampling
This study analyses data from the Zurich Study, an age
cohort representative of the general population of the
canton of Zurich, which accounts for approximately one
sixth of the total Swiss population. The design was pro-
spective, longitudinal, long-term, and naturalistic. The
Zurich Study comprised a cohort of 4547 subjects (2201
men, 2346 women) representative of the canton of Zurich
in Switzerland, who were screened in 1978 with the
Symptom Checklist (SCL-90R), when the men were 19
and the women 20 years old. Male and female participants
were sampled using different approaches. In Switzerland
every male person undergoes military screening at the age
of 19. With the consent of the military authorities but in-
dependently of their procedure, 50% of all male conscripts
on the recruiting lists were randomly screened. Of these,
99.7% were included (n = 2201) (refusal rate 0.3%). The fe-
male sample was based on the complete population regis-
ters (civil status registers) of the canton of Zurich, from
which 50% of the women born in 1958 were randomly
selected. They were mailed questionnaires, to which n =
2346 (75%) responded. Because of the lower response rate
of women with poorer educational levels, the interview
sample was corrected for this bias. Written informed
consent was obtained from all participants.
For economic reasons and in the interest of the long-
term design of the study, in the second stage, a stratified
sample of 591 subjects (292 men, 299 women) was se-
lected for interview. The interview sample was enriched
with persons reporting high levels of psychopathological
symptoms and distress and therefore at risk for the de-
velopment of psychiatric syndromes. Thus two thirds
(n = 394) of the final interview sample consisted of ran-
domly selected “high scorers” (defined by the 85th
percentile or more on the Global Severity Index (GSI) of
the SCL-90-R) and the remaining third (n = 197) of low
scorers (<85th percentile). A detailed description of the
Zurich Study design and method was published
previously [11].
The use of such a two-phase method, consisting of initial
screening and subsequent interview with a subsample
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stratified to enrich the sample with individuals of specific
interest, was recommended in epidemiology [12].
Altogether, seven interview waves were carried out, when
the participants were aged 20(m)/21(f) to 49/50: in 1979
(n = 591), 1981 (n = 456), 1986 (n = 457), 1988 (n = 424),
1993 (n = 407), 1999 (n = 367), and 2008 (n = 335,
reflecting a 56.9% retention rate). Details of the inter-
view waves and the drop-out rates and characteristics
are published elsewhere [11]. The initial ratio of high-
scorers to low-scorers (two thirds: one third) did not
change significantly over the 30 years of the study;
the sample therefore remained representative of the
general population. The interview sample during the
period 1981–2008 comprised 490 participants, who,
weighted for stratified sampling, represent 2342
subjects (1141 men, 1201 women).
Data from the year 1979 were not included in the
current analysis, because at that interview the assess-
ment of symptom duration was limited to 1 month.
In all subsequent interview waves a symptom dur-
ation up to 12 months was assessed, thus allowing
the definition of chronic gastrointestinal problems
(see below). We accordingly included the 490 subjects
who took part in the interviews between 1981 and
2008. For each interview, all members of the initial
sample of 1979 (n = 591) were followed up. In order
to be included in our analysis, a participant had to
have been interviewed at least once between 1981
and 2008. Because of the varying response rates the
number of participants happened to be slightly higher
in 1986 (n = 457) than in 1981 (n = 456).
Instruments and measures
The instruments used comprised the Structured
Psychopathological Interview and Rating of the Social
Consequences of Psychological Disturbances for
Epidemiology (SPIKE) [13], a clinical syndrome list (SL),
the revised 90-item symptom check list (SCL-90R), a life-
event inventory, and scales measuring coping behaviour
and dissimulation. The interviews were conducted in the
subjects’ homes by specially trained psychologists or
psychiatrists and focused mainly on the past year in order
to minimise forgetting.
The SPIKE is a semi-structured interview specifically
developed for epidemiological surveys in psychiatric re-
search. It assesses socio-demography, psychopathology,
substance use, medication, health service use, impairment,
and social activity. Data on its reliability and validity have
been published previously [14]. Unlike other diagnostic in-
terviews, which apply DSM (diagnostic and statistical
manual) diagnoses using a top-down approach with
multiple cut-offs, the SPIKE uses a bottom-up approach,
assessing the past-year presence of about 14 somatic
(including gastrointestinal) and 15 psychiatric
syndromes, for each of which it checks symptoms,
duration, frequency of episodes, distress, impairment
and treatment.
The interviewers collected data on a total of 26
comorbid conditions: repeated panic attacks, anxiety
(≥1 month Generalised Anxiety Disorder (GAD)), major
depression (unipolar depression), bipolar depression, simple
phobia, specific phobia, social phobia, agoraphobia,
obsessive-compulsive disorder, suicidality, drug
dependence, sedative/ tranquilliser dependence, alcohol
dependence, smoking, bulimia, obesity, fatigue, sexual
problems, sleep disorders, hypertension, hypotension, back
pain, headache, other pain (not classified), cardiovascular
symptoms and asthma spectrum conditions.
Interviewees were asked about specific gastrointestinal
symptoms, for example: pain in the stomach, burning in
the stomach, pressure in the stomach, nausea, vomitus,
constipation, diarrhoea, intestinal pain, bloating, blood
in the stool. Assessment on this pure symptom level
provides obvious face and content validity. We defined
as stomach symptoms, those symptoms perceived in the
upper abdominal region (pain, burn, pressure, nausea,
vomitus). Intestinal symptoms were defined as those
located in the lower abdominal region (constipation,
diarrhoea, pain, pressure, bloating). Participants were only
asked about their symptoms; the cause of the symptoms
was not evaluated. Consequently, liver and pancreas disor-
ders could also cause gastrointestinal symptoms of the
upper and lower gastrointestinal tract.
Participants were also specifically questioned about the
duration and the intensity of their symptoms, in particular
to specify the number of days they had experienced
gastrointestinal symptoms over the past 12 months [11].
We defined as subacute, gastrointestinal symptoms lasting
more than 1 week but less than 3 months: 1 week<= sub-
acute<=3 months. Chronic symptoms that lasted 3 months
or more: chronic≥3 months. An exception was made for
diarrhoea: 1 week≤subacute< 1 month and chronic, which
was defined as subacute if lasting 1 week or more but less
than 1 month and as chronic ≥1 month. Acute gastro-
intestinal symptoms (< 1 week = 7 days) were excluded,
because of the high probability that they were caused by a
viral or bacterial infection. The intensity of the gastro-
intestinal symptoms/suffering experienced was
subjectively quantified on a 0–100 mm “thermometer”
scale: 0 = no distress/symptoms, 100 = maximum
distress/symptoms [15]. The degree of distress/sub-
jective suffering associated with a condition is an in-
dividual’s most important measure of their state of
health and the primary reason for seeking help.
The main outcome was measured on the symptom
level, for example, nausea, pressure, constipation, etc.
The concomitant comorbidities were classified on the
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syndrome/disorder level, for example, major depression,
specific phobia, asthma, etc.
Analysis
The analysis of prevalence was limited to the period
1981–2008. All participants in at least one interview were
included and analysed by weighting for stratified sampling.
Descriptive statistics consisted of means (M) and standard
deviations (SD) if the frequency distribution was approxi-
mately symmetrical, and of medians and quartiles (q1 and
q3) if it was not. All data on prevalence were weighted
back to the composition of the original, representative,
population-based age cohort, comprising women born in
1958 and men born in 1959 living in the canton Zurich;
quantification was in percentages (%) [13, 14].
Associations of gastrointestinal symptoms (present/
absent as dependent variable) with psychiatric
conditions were analysed by stepwise multivariate
logistic regression to various comorbid conditions as
independent variables, adjusting for sex and education
level (confounding co-variates) in the interview sample of
n = 490. We used backward stepwise regression, i.e., after
each step the least significant variable was excluded. The
observation period of the Zurich age cohort ended in
2008; thus associations were not confounded by age. The
associations were expressed as odds ratios (ORs) with cor-
responding intervals of 99% confidence (99% CI). A type I
error of 1% was chosen because the logistic models were
stepwise determined after a maximum of 5 steps, which
leads to a Bonferroni correction of 0.05/5. The OR quanti-
fies the relative frequency (often also termed “risk”) of
gastrointestinal symptoms if a given characteristic is
present or not. All analyses were performed using SAS 9.3
for Windows (SAS Inc., Cary, NC, USA).
Results
Prevalences
Over the period 1981–2008 prevalence rates for any
(subacute and chronic) stomach symptoms was 20.9%
and for any intestinal symptoms 21.3%. (Tables 1 and 2).
Among the gastric symptoms (Table 1), overall pain/
burn/pressure was more common (18.1%) than nausea/
vomitus (11.0%). For subacute stomach pain, burn
(reflux), pressure the prevalence rate was 10.8% in
women and 7.9% in men. The rates by gender for the
corresponding chronic symptoms were 13.2 and 4.1%.
Indeed, the prevalence rates for all examined symptom
groups were consistently higher in women, with the dif-
ferences being statistically highly significant except in
the subgroup of any subacute symptoms. The widest
gender difference was 10.1% vs 0.6% for chronic nausea,
vomitus. Overall, there was a female preponderance
(26.4% vs 15.2%) for any (subacute + chronic) gastric/
stomach symptoms.
The prevalence rates in every group of intestinal symp-
toms examined were also higher in women (Table 2).
With the exception of diarrhoea, the gender differences
were statistically highly significant: constipation subacute
7.7% vs 3.4%, chronic 8.1% vs 3.1%; pain/pressure/bloat-
ing subacute 11.3% vs 5.7%, chronic 11.4% vs 4.6%.
Overall, the female preponderance was 27.6% to 14.6%
for any (subacute + chronic) intestinal symptoms. Pain/
pressure/bloating was the most prevalent intestinal syn-
drome (16.7%).
Distress (scale 0–100)
The highest distress levels were found in 54 subjects
with chronic gastric symptoms, with a mean of 67.9
(standard deviation: 24.0), followed by 76 subjects with
subacute gastric symptoms with a mean of 55.4
Table 1 Numbers and weighted prevalence rates (%) of stomach symptoms by gender
N M+ F% M% F% p
Pain, burn, pressure subacute≥1 week 65 9.3 7.9 10.8 0.012
chronic≥3 months 51 8.8 4.1 13.2 < 0.001
subacute+chronic 116 18.1 12.0 24.0 < 0.001
Nausea, vomitus subacute≥1 week 36 7.0 4.8 9.0 < 0.001
chronic≥3 months 40 5.5 0.6 10.1 < 0.001
subacute+chronic 76 11.0 4.5 19.1 < 0.001
Pain, burn, pressure with nausea, vomitus subacute≥1 week 35 4.9 2.9 7.1 < 0.001
chronic≥3 months 33 5.0 0.6 9.0 < 0.001
subacute+chronic 68 9.9 3.5 16.1 < 0.001
Any symptoms subacute≥1 week 54 11.6 11.0 12.2 0.385
chronic≥3 months 76 9.3 4.2 14.2 < 0.001
subacute+chronic 130 20.9 15.2 26.4 < 0.001
Legend: n = number in the sample, prevalences: rates, back-weighted to the general population, M =male, F = female, p = type I error that the prevalences of m
and f are different (two-sided)
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(standard deviation: 26.3). There were no significant
distress-related gender differences (Table 3).
Comorbid conditions
Stepwise logistic regression modelling selected all condi-
tions having significant associations with gastrointestinal
symptoms, adjusting for sex and level of education; no
adjustment for age was necessary, since all interviewees
had the same age per assessment time point.
Subacute stomach symptoms (Fig. 1) were found to be
moderately associated with anxiety (OR = 1.85, 99%-CI:
1.20–2.86), bipolar disorder (1.83, 1.18–2.82) and back
pain (1.48, 1.01–2.17). An inverse (protective) associ-
ation was found between subacute stomach symptoms
and obesity (0.41, 0.19–0.88).
Chronic stomach symptoms (Fig. 2) were strongly
associated with fatigue (OR = 9.96, 99%-CI: 5.53–17.94)
and moderately with high blood pressure (4.67,
2.80–7.78), social phobia (3.00, 1.70–5.27) and anxiety
(2.64, 1.60–4.36). An inverse association was found with
bulimia/binge eating (0.20, 0.09–0.45).
Subacute intestinal symptoms (Fig. 3) were strongly
associated with panic attacks (OR = 4.00, 99%-CI:
2.43–6.59), bulimia/binge eating (3.97, 2.30–6.82), anx-
iety (3.37, 2.23–5.08) and moderately with unipolar
major depression (2.05, 1.34–3.15). Inverse associations
were documented for sleep disorders (0.45, 0.29–0.71),
alcohol dependence (0.42, 0.27–0.65) and agoraphobia
(0.34, 0.14–0.82).
Chronic intestinal symptoms (Fig. 4) were very
strongly associated with fatigue (OR = 9.02, 99%-CI:
4.92–16.54), social phobia (4.77, 2.66–8.54) and bulimia
(4.76). A moderate association was found with bipolar
disorder (3.07, 1.69–5.57). Inverse (protective) associa-
tions were documented for obesity (0.20, 0.09–0.46),
specific/simple phobia (0.28, 0.15–0.52) and anxiety
(0.21, 0.09–0.52).
Discussion
This study provides new insights into the longitudinal epi-
demiology of functional gastrointestinal symptoms in
Switzerland. In our sample of 490 participants, male and
female, one in five complained of subacute or chronic
stomach symptoms and of subacute or chronic intestinal
symptoms. Stomach symptoms were defined as symptoms
of the upper gastrointestinal tract (pain, burn, pressure,
nausea, vomitus) and intestinal symptoms as symptoms of
the lower gastrointestinal tract (constipation, diarrhoea,
pain, pressure, bloating). Pain and pressure were most
prevalent among the gastric as well the intestinal symp-
tom groups. For both sexes, the prevalences of subacute
and chronic complaints were comparable in most of the
symptom groups.
Table 2 Numbers and weighted prevalence rates (%) of intestinal symptoms by gender
N M+ F% M% F% p
Constipation subacute≥1 week 39 5.6 3.4 7.7 < 0.001
chronic≥3 months 51 5.7 3.1 8.1 < 0.001
subacute+chronic 90 11.3 6.5 15.8 < 0.001
Diarrhoea subacute≥1 week 42 4.9 4.2 5.5 0.133
chronic≥1 month 57 7.7 6.7 8.7 0.068
subacute+chronic 99 12.6 10.9 14.2 0.013
Pain, pressure, bloating subacute≥1 week 47 8.6 5.7 11.3 < 0.001
chronic≥3 months 66 8.1 4.6 11.4 < 0.001
subacute+chronic 113 16.7 10.4 22.7 < 0.001
Any symptoms subacute≥1 week 57 9.0 6.3 11.7 < 0.001
chronic≥1 or 3 months 91 12.2 8.3 16.0 < 0.001
subacute+chronic 148 21.3 14.6 27.6 < 0.001
Legend: n = number in the sample, prevalences: rates, back-weighted to the general population, M =male, F = female, p = type I error that the prevalences of m
and f are different (two-sided)
Table 3 Distress levels of any symptoms (0 = no to 100 =maximum
distress)
Gastric N mean sd Intestinal n mean sd
subacute all 76 55.4 26.3 subacute all 57 50.9 28.1
subacute m 33 52.5 26.5 subacute m 20 46.0 26.4
subacute f 43 57.6 26.2 subacute f 37 53.5 28.9
p (m vs f) 0.399 0.330
chronic all 54 67.9 24.0 chronic all 91 51.9 30.3
chronic m 17 69.3 23.9 chronic m 33 50.5 32.8
chronic f 37 67.3 24.3 chronic f 58 52.7 29.1
p (m vs f) 0.776 0.733
Legend: n = number in the sample, m =male, f = female, mean = arithmetic
mean, sd = standard deviation, p = type I error that the distress of m and f are
different (two-sided)
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In a review of the prevalence of functional dyspepsia,
two studies could be found that were comparable to
ours [16]. A British study of a randomly selected sample
of 20% of patients registered at two health centre prac-
tices who were examined by endoscopy to exclude or-
ganic disease reported an estimated prevalence of
functional gastrointestinal symptoms of 11.5%. A care-
fully designed endoscopy study of the inhabitants of a
Norwegian community (Sørreisa) aged 20–69 found a
prevalence of functional gastrointestinal disorders of
14.7%. Comparing those results (11.5% and 14.7%) to
our own prevalence rates of around 20% of any gastric
symptoms, it may be concluded that 1/2 to 3/4 of the
gastric symptoms are functional in our sample.
Our analysis focused on gastrointestinal (GI) symptoms
of at least 1 week’s duration, which excludes acute infec-
tions but covers most of the functional syndromes. People
with functional GIs suffer by definition from disorders
without somatic background, which can be very difficult
to understand and to accept. The symptoms, which cause
shame and embarrassment, tend to isolate the sufferer
and impact heavily on their working and social lives. It
may thus be assumed that there is a bidirectional relation-
ship between functional GI symptoms and psychiatric
Fig. 1 Associations with subacute stomach symptoms (n = 76 with, n = 410 without symptoms): Odds ratios (OR), 99% CI, adjusted for sex and
education level. Explained variance: 15.7%. Legend: Odds ratios (OR), 99% CI, adjusted for sex and education level
Fig. 2 Associations with chronic stomach symptoms (n = 54 with, n = 372 without symptoms): Odds ratios (OR), 99% CI, adjusted for sex and
education level. Explained variance: 52.4%. Legend: Odds ratios (OR), 99% CI, adjusted for sex and education level
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disorders, with the latter being both partial cause and fre-
quent product of the former, creating a vicious circle.
We found the highest distress levels in subjects with
chronic followed by subacute gastric symptoms. The
correlation between chronic symptoms and higher dis-
tress levels might be explained by exhaustion (fatigue/
neurasthenic syndrome) as discussed later. Women and
men were equally distressed by subacute and chronic
gastrointestinal symptoms although more women had
GI illnesses.
As initially hypothesised, our study found higher fe-
male prevalence rates in all subgroups of gastrointestinal
syndromes examined. Our findings are in line with earl-
ier studies. In Smith’s epidemiological study of 1978
women with IBS outnumbered men by a ratio of 2.3:1
[1]. However, a recent Japanese report showed a male
predominance for the IBS-subtype with diarrhoea and a
female predominance for the IBS-subtype with constipa-
tion, the overall prevalence of IBS being assessed at
13.1%, 15.5% for females and 10.7% for males [8].
In our study the strongest associations overall were
found between fatigue and chronic stomach and chronic
intestinal symptoms. This finding is compatible with the
results of a recent study showing a strong association
Fig. 3 Associations with subacute intestinal symptoms (n = 78 with, n = 345 without symptoms): Odds ratios (OR), 99% CI, adjusted for sex and
education level. Explained variance: 38.2%. Legend: Odds ratios (OR), 99% CI, adjusted for sex and education level
Fig. 4 Associations with chronic intestinal symptoms (n = 76 with, n = 345 without symptoms): Odds ratios (OR), 99% CI, adjusted for sex and
education level. Explained variance: 45.7%. Legend: Odds ratios (OR), 99% CI, adjusted for sex and education level
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between fatigue and depression in patients with Crohn’s
disease and ulcerative colitis [17]. This raises the peren-
nial question of “cause or effect”, as fatigue could be an
important aetiological factor in the development of func-
tional gastrointestinal symptoms but also the result of
those symptoms. The key role of fatigue in chronic
gastrointestinal symptoms needs further research.
Hypertension was relatively strongly associated with
chronic stomach symptoms. Hypertension could be a
primary or secondary manifestation of rhythm distur-
bances or angina, which are thought to be associated
with gastrointestinal symptoms. This hypothesis is sup-
ported by an interesting review, which found associa-
tions between rhythm disturbances, linked angina
pectoris and oesophageal diseases [18]. Further, inflam-
matory large bowel disorders, were associated with
hypotension and hypertension.
We found a moderate association between back pain
and subacute stomach symptoms. Interestingly, obesity
was inversely correlated with subacute stomach and
chronic intestinal symptoms. Or rather, conversely, it is
possible that people who do not suffer from stomach or
intestinal problems are more prone to obesity than those
who do; this may be due to the fact that gastrointestinal
problems limit food intake. Bulimia and binge eating,
however, had a fourfold higher association with subacute
and chronic intestinal symptoms but an inverse associ-
ation with chronic stomach symptoms. To the best of
our knowledge there is no literature that elucidates these
relationships.
In line with our initial hypothesis that GI symptoms
correlate with psychiatric disorders, we found that some
anxiety states (social phobia, anxiety ≥1 month Generalised
Anxiety Disorder – GAD) tended to be associated to vary-
ing degrees with every subgroup of gastrointestinal disor-
ders (Figs. 1, 2, 3 and 4). An exception was specific phobia,
which was negatively associated with chronic intestinal
symptoms.
In our study major mood disorders were also varyingly
associated with GI symptoms: bipolar disorder with sub-
acute stomach and chronic intestinal symptoms, and
major depression with subacute intestinal symptoms but
not with the chronic forms.
There is ample literature on the role of emotional factors
in functional gastrointestinal symptoms. An early study by
Young et al. reported a “psychiatric illness” in 72% of a
group of participants with irritable bowel syndrome (IBS),
compared to 18% in the control group [19]. The preva-
lence of depression and anxiety in patients with IBS and
ulcerative colitis (UC) has been reported in three studies.
Hartono et al. found an excess prevalence of depression
and anxiety of 38.7% and 6.5% respectively in IBS patients
relative to healthy patients [20]. Uz et al. reported an ex-
cess prevalence of depression or anxiety of 34% and 2% in
patients with IBS in comparison to healthy controls [21].
Shah et al. conducted a systematic review on prevalence
rates of anxiety and depression in patients with IBS and
with UC. In addition to the above-mentioned prevalence
rates for anxiety and depression in IBS patients, the au-
thors documented an excess prevalence of anxiety in UC
patients relative to healthy controls of 41.7% (22.2%
baseline prevalence in healthy controls) based on a State-
Trait Anxiety Inventory (STAI) score greater than 40.
Excess depression of 38.9%, with a baseline prevalence of
11.1% in the healthy population, was evaluated with a
Zung Depression Scale (ZDS) score greater than 49. The
authors concluded that both IBS and UC are associated
with psychological disorders versus healthy controls and
that the association between irritable bowel syndrome and
psychological factors might be attributed to the psycho-
logical suffering caused by this chronic and debilitating
disease [9].
Further studies have confirmed associations between
GI symptoms and syndromes and anxiety and depres-
sion. A Canadian study of 2015 showed an association
between irritable bowel syndrome and general anxiety
[22]. Other recent studies have reported an association
between gastrointestinal reflux disease and visceral anx-
iety [23]. An American study, which focused on correla-
tions of anxiety disorders and physical health conditions
in elderly Americans, found a statistically significant as-
sociation between certain anxiety forms and gastrointes-
tinal disease [24]. A study of 2016 showed a clear
association of gastrointestinal reflux disease with anxiety
and depression in Australian men [25].
Our findings are compatible with the above studies as
regards a significant association between gastrointestinal
symptoms and anxiety. However, the association with
depressive syndromes in our data was limited to sub-
acute intestinal symptoms only.
The significant associations found between GIs and
other somatic and psychiatric disorders, could suggest
the need to modify the clinical approach and treatment
in the field. In particular, the evaluation and treatment
of patients with gastrointestinal symptoms would benefit
from the integration of psychiatric and/or psychological
aspects, broadening the perspective on the pathophysio-
logical mechanisms involved.
The most important strengths of the Zurich Cohort
Study are its long-term longitudinal and comprehensive
design covering all relevant psychiatric and somatic is-
sues. The study greatly benefited from the continued
large number of participants and from the multiple
follow-ups conducted over decades. The multivariate
logistic models attained high variances, i.e. explained a
large proportion of the characteristics of gastrointestinal
symptoms, indicating that the assessment of the deter-
mining factors was comprehensive. Furthermore, the
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logistic regression models were adjusted for sex and level
of education, which were both kept in the model
irrespective of their significance and which are well-
known important confounders.
The study also has limitations: by virtue of its longitu-
dinal design the participation rate fluctuated across the six
interviews (1981–2008). Furthermore, the associations
were examined over the whole observation period and no
time-linked cause-effect relationships were analysed. No
causal conclusions can therefore be drawn from our asso-
ciation data. Finally all data are interview based without
physical examination.
Conclusions
This study provides new insights into the epidemiology
of gastric and intestinal symptoms in young and middle-
aged persons in the general population.
Functional gastric and intestinal symptoms are re-
markably common in the general population, especially
in women. We found very strong associations between
fatigue/neurasthenia and both conditions and significant
associations with various somatic and mental (especially
anxiety-related) syndromes. Since there can be no early
clarification of the “cause or effect” relationship between
GI symptoms and accompanying psychiatric syndromes,
screening of functional GI patients followed by the inte-
gration of appropriate psychiatric and/or psychological
treatment could be an important tool in addressing ef-
fectively the functional part of their condition.
More research is needed to clarify the role of fatigue,
anxiety disorders and major mood disorders as primary
cause or secondary expression of gastrointestinal
symptoms.
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